|
|
Lakefront Biotherapeutics ADR
NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/18/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,856.98 mln
Earnings Date08/10/2026
P / E
3.29
Deeply undervalued
1-Year Forecast
23.33
Downside risk
Key Fundamentals
EPS8.60
P/E3.29
ROE17.44
RPS18.53
ROIC101
ROA13.81
Interest Cover862
EBITDA, mln469
EV / EBITDA-3.49
EV / EBIT-3.49
Revenue, mln1,221
EV / Revenue-1.34
Financial Strength
Altman Z-Score9.84
Piotroski F-Score
6
/ 9
Beneish M-Score0.58
Price to Graham Number0.23
1-Year Target Price23.33
Short Ratio11.35
Short % of Float4.63
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-2.21% |
23
/ 100
 |
| 1 Month |
6.35% |
72
/ 100
 |
|
| |
